AmplifyMD is a technology company.
AmplifyMD has raised $25.0M across 2 funding rounds.
AmplifyMD has raised $25.0M in total across 2 funding rounds.
AmplifyMD has raised $25.0M in total across 2 funding rounds.
AmplifyMD's investors include Forerunner Ventures, F-Prime Capital Partners, Greylock, Cota Capital, Khosla Ventures, Lowercarbon Capital, SV Angel, Y Combinator, Yes VC.
AmplifyMD is a healthtech portfolio company that builds an EHR-integrated virtual care platform combined with a national network of remote specialists, enabling hospitals and health systems to deliver multispecialty telehealth at scale.[1][3][5] It serves healthcare facilities facing specialist shortages, fragmented telehealth tools, and rising demand for efficient care, solving problems like poor EHR interoperability, administrative burdens, high costs, and inconsistent access to specialists by streamlining workflows from scheduling to billing—making virtual care up to 2x more efficient while improving outcomes, revenue, and readmissions.[2][4][5] The platform supports diverse use cases including emergent care (e.g., TeleStroke), inpatient coverage, asynchronous consults, SNF/LTAC, virtual clinics, and direct-to-patient services, with built-in AI automation, analytics, and configurability that drives growth momentum evidenced by awards like Fast Company's Next Big Things in Tech 2023 and investments from F-Prime Capital in 2022.[2][3]
Today, AmplifyMD powers hundreds of hospitals to expand capacity, add specialties, and achieve cost savings—such as reduced administrative costs, lower 30-day readmission rates, and fewer remote MD hours—positioning it as a leader in scalable virtual specialty care.[1][5]
AmplifyMD was founded in 2019 by Meena Mallipeddi (CEO) and Anand Nathan to address gaps in access to physician specialists, inspired by the need for innovative virtual care models amid healthcare's evolving demands.[1] Mallipeddi, with her expertise in healthcare technology, and Nathan identified how fragmented telehealth exacerbated IT complexity and provider burdens, prompting them to build a platform from the ground up with deep EHR integrations, intelligent automation, embedded AI, and a network of remote specialists.[1][2] Early traction came from solving real-world pain points for hospitals, leading to rapid adoption; by 2022, F-Prime Capital's investment accelerated network expansion and credibility, while 2023's Fast Company award validated its breakthrough potential amid exploding telehealth use.[2][3]
Pivotal moments include architecting a data model for end-to-end efficiency and achieving SOC 2 compliance, which humanized their mission: treating clients as partners, prioritizing quality without shortcuts, and continuously iterating based on physician, hospital, and patient feedback.[1][4]
AmplifyMD stands out in virtual care through these key strengths:
These features prioritize care teams, making telehealth simpler and more sustainable than point solutions.[2]
AmplifyMD rides the telehealth scalability wave post-pandemic, where fragmented legacy tools have inflated IT costs and complicated workflows amid specialist shortages and value-based care pressures.[2][5] Timing is ideal as health systems demand EHR-native platforms to handle rising volumes—emergent, inpatient, and transitional care—while AI automation addresses admin overload, enabling "do more with less" amid labor constraints.[1][4][7] Market forces like regulatory support for telehealth, AI adoption in healthcare, and cost-efficiency mandates favor AmplifyMD, which influences the ecosystem by standardizing virtual care models, reducing readmissions, and empowering smaller facilities via its network and analytics.[3][5][6]
By integrating clinical and tech solutions, it counters telemedicine fragmentation, as noted in KLAS analysis, positioning it to shape sustainable provider coverage in a $100B+ virtual care market.[6]
AmplifyMD is primed for expansion, leveraging AI advancements and network growth to dominate multispecialty virtual care, potentially capturing more health systems switching from legacy platforms for 20-50% efficiency gains.[5][7] Trends like deeper AI-clinical integration, hybrid care models, and payer incentives for remote services will propel it, with F-Prime's backing enabling national scaling and new specialties.[3][7] Its influence may evolve from gap-filler to ecosystem orchestrator, redefining specialist access and tying back to founders' vision: transforming healthcare through measurable, patient-first innovation without compromise.[1]
AmplifyMD has raised $25.0M across 2 funding rounds. Most recently, it raised $20.0M Series B in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2025 | $20.0M Series B | Forerunner Ventures, F-Prime Capital Partners, Greylock | |
| Feb 1, 2021 | $5.0M Seed | Cota Capital, Greylock, Khosla Ventures, Lowercarbon Capital, SV Angel, Y Combinator, Yes VC |